Amicus Therapeutics

OPFOLDA

Manufacturer:

Amicus Therapeutics

Opfolda HCPCS:

J1202

HCPCS Code Descriptor:

Miglustat, oral, 65 mg

Category:

J Code

Opfolda NDCs:

71904-0300-01, 71904-0300-02, 71904-0300-03

Primary Type:

Genetic Disorder

Generic/Specialty Status:

Single-Source

Package Type:

Not Found

Route of Administration:

Intravenous

Potential NDC Listing Errors:

Our team did not identify any potential listing errors/discrepancies for the NDCs mapped to this HCPCS code.

About Opfolda:

OPFOLDA is aligned to the J Code: J1202. OPFOLDA is a Genetic Disorder product produced by Amicus Therapeutics and administered via the oral route of administration.

ACCESS PRICING AND MORE BY REGISTERING

J1202 Added Date:

4/1/24

J1202 Effective Date:

4/1/24

J1202 Deactive Date:

HCPCS Active

We have not yet identified a manufacturer source of billing and coding information for Opfolda
Opfolda patient assistance information can be found through Amicus Therapeutics at the URL: https://www.amicusassist.com/
Opfolda prescribing information can be found at the link below:
Information regarding Opfolda’s potential side effects can be found at MedlinePlus